Literature DB >> 21906078

Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation.

F Bossi1, B Frossi, O Radillo, M Cugno, A Tedeschi, P Riboldi, R Asero, F Tedesco, C Pucillo.   

Abstract

BACKGROUND: Chronic urticaria (CU) is one of the most common skin disorders whose pathogenic mechanisms are not fully clarified. Autoimmune aetiology can be ascribed to 45% of patients with CU, and basophil histamine release is positive in 40% of cases. Our aim was to use a novel approach to evaluate the serum permeabilizing effect to identify the mediators of endothelial cell (EC) leakage and to define the role of mast cells (MCs) in the process.
METHODS: Permeabilizing activity of sera from 19 patients with CU and 11 healthy blood donors was evaluated by measuring serum-induced degranulation of two MC lines, expressing (LAD2) or lacking (HMC-1) the IgE receptor. Mast cell supernatant (SN) was then incubated with an EC monolayer, and endothelial permeability was evaluated by Fluorescein isothiocyanate-bovine serum albumin leakage in a transwell system.
RESULTS: All 19 patient sera failed to induce direct EC leakage, but 15/19 and 17/19 promoted degranulation of HMC-1 and LAD2, respectively. Interestingly, 85% of autologous serum skin test-negative sera were able to cause MC degranulation. Also, 17/19 SNs from HMC-1 and all SNs from LAD2 incubated with CU sera increased endothelial permeability. Endothelial cell leakage remained unchanged after Ig depletion and was prevented by antihistamine, platelet-activating factor or leukotriene antagonist.
CONCLUSIONS: Our study shows that CU sera are able to degranulate MCs through an IgE- and IgG-independent mechanism. The nature of histamine-releasing factors involved is still unclear, but our finding opens new ways to the understanding of the pathogenesis of CU, particularly in patients not showing circulating autoantibodies to FcεRI or IgE.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906078     DOI: 10.1111/j.1398-9995.2011.02704.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  17 in total

Review 1.  Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Authors:  A P Kaplan; A M Giménez-Arnau; S S Saini
Journal:  Allergy       Date:  2017-01-04       Impact factor: 13.146

Review 2.  Urticaria and Angioedema: an Update on Classification and Pathogenesis.

Authors:  Susanne Radonjic-Hoesli; Kathrin Scherer Hofmeier; Sara Micaletto; Peter Schmid-Grendelmeier; Andreas Bircher; Dagmar Simon
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  Chronic Spontaneous Urticaria: The Devil's Itch.

Authors:  Sarbjit S Saini; Allen P Kaplan
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jul - Aug

Review 4.  Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.

Authors:  Eric Schauberger; Miriam Peinhaupt; Tareian Cazares; Andrew W Lindsley
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 5.  Mast cell and autoimmune diseases.

Authors:  Yunzhi Xu; Guangjie Chen
Journal:  Mediators Inflamm       Date:  2015-04-05       Impact factor: 4.711

6.  Nickel sensitization and dietary nickel are a substantial cause of symptoms provocation in patients with chronic allergic-like dermatitis syndromes.

Authors:  Andrea Antico; Roberto Soana
Journal:  Allergy Rhinol (Providence)       Date:  2015-03-05

7.  A disease marker for aspirin-induced chronic urticaria.

Authors:  Chia-Wei Hsieh; Jeen-Wei Lee; En-Chih Liao; Jaw-Ji Tsai
Journal:  Int J Mol Sci       Date:  2014-07-15       Impact factor: 5.923

8.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

Review 9.  Immunological events in chronic spontaneous urticaria.

Authors:  Marta Ferrer
Journal:  Clin Transl Allergy       Date:  2015-08-25       Impact factor: 5.871

Review 10.  Chronic urticaria: Indian context-challenges and treatment options.

Authors:  Sujoy Khan; Anirban Maitra; Pravin Hissaria; Sitesh Roy; Mahesh Padukudru Anand; Nalin Nag; Harpal Singh
Journal:  Dermatol Res Pract       Date:  2013-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.